2020 has proven to be a volatile year for investment managers due to COVID-19. The emergence of new biotech and healthcare companies have tested their strategies even more than before.
Global markets have been adversely impacted by lockdowns, and as a result, Allocators have had to weather the storm of turbulent times. Managers have adapted their strategies in finding new ideas, especially in Healthcare, to ensure they continue to provide value for potential investors looking for long term growth in this ever- evolving sector.
On the 21st of October 2020 we had the privilege of hosting Dr Bianca Ogden, Virologist Portfolio Manager from Platinum Asset Management to share their approach to finding quality companies in Healthcare and Biotech.
In this webinar we aimed to provide insights into:
- The most evident global Healthcare and Biotech trends
- Current and future investment opportunities in the Healthcare sector
- Tools empowering frictionless data aggregation, analysis and management
Watch the webinar
Dr Bianca Ogden
Portfolio Manager at Platinum Asset Management
Bianca joined Platinum in 2003 and manages its Health Care strategy and sector team. She worked previously as a molecular biologist at J & J and Novartis. Her rich scientific base and industry knowledge allow her to delve deep in fundamentals, identifying companies with solid foundations in scientific research. She has a PhD from UCL and is a German native.
Founder and CEO at Allocator
Before founding Allocator, Ryan was on the investment team at Stenham Advisors, a $4bn fund of hedge funds. At Stenham, he completed due diligence on macro & equity funds around the world, led investments of totalling over $300m, and developed a range of quantitative risk analytics tools. He was also involved in the launch of the Stenham Healthcare fund of funds.
Who are Allocator
Allocator is a software and data-as-a-service company, providing integrated data management, analytics and workflow solutions to the alternative investments industry. We empower private capital investors to boost efficiency and accuracy by transforming their operations and research processes. Our world-class analytics platform provides Allocators easy access to all their investment data in a standardised and consolidated format, allowing them to focus on their core investment activities.